Grapefruit News and Research

RSS
Xylitol and grapefruit seed extract nasal spray could help COVID-19 patients

Xylitol and grapefruit seed extract nasal spray could help COVID-19 patients

Natural compund in cedar and grapefruit skin could help repel mosquitoes and ticks says CDC

Natural compund in cedar and grapefruit skin could help repel mosquitoes and ticks says CDC

Using supercomputers to screen drugs for deadly heart arrhythmias

Using supercomputers to screen drugs for deadly heart arrhythmias

Aromatherapy may alleviate nurses’ on-the-job stress, study suggests

Aromatherapy may alleviate nurses’ on-the-job stress, study suggests

Sugary drinks have a negative impact on blood cholesterol, which increases heart disease risk

Sugary drinks have a negative impact on blood cholesterol, which increases heart disease risk

The Science Behind the Beer and Brewing Industry

The Science Behind the Beer and Brewing Industry

Anti-cancer effects of lycopene in tomatoes canceled out by iron-rich foods

Anti-cancer effects of lycopene in tomatoes canceled out by iron-rich foods

FDA expands approval of cystic fibrosis treatment to include pediatric patients as young as 6 years old

FDA expands approval of cystic fibrosis treatment to include pediatric patients as young as 6 years old

Study confirms QT-prolonging effects of grapefruit juice

Study confirms QT-prolonging effects of grapefruit juice

Coffee, sugary drinks, or alcohol? It's in your genes.

Coffee, sugary drinks, or alcohol? It's in your genes.

Using computer model to visualize brain's internal valuation system

Using computer model to visualize brain's internal valuation system

Community hospitals link arms with prestigious facilities to raise their profiles

Community hospitals link arms with prestigious facilities to raise their profiles

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Avoidable sepsis infections send thousands of seniors to gruesome deaths

Avoidable sepsis infections send thousands of seniors to gruesome deaths